Related Experiment Video
Updated: Jun 25, 2025
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Platelet microparticles influence gene expression and modulate biological activities of chronic myeloid leukemia
Fariba Nikravesh1, Roohollah Mirzaee Khalilabadi1, Alireza Farsinejad1,2
1Department of Hematology and Medical Laboratory Sciences, Faculty of Allied Medicine, Kerman University of Medical Sciences, Medical University Campus, Haft-Bagh Highway, Kerman, Iran.
Background:
The current understanding emphasizes the intricate interplay between the Leukemic cell and its environment. Platelet-derived microparticles play a crucial role in facilitating intercellular communication and contribute to the complex landscape of cancer pathology. This study aimed to investigate the influence of platelet-derived microparticles on cell proliferation, apoptosis, and the expression of key genes, including P53, P21, Cyclin D1, Bax, and Bcl-2, within the context of a chronic myeloid leukemia cell line (K562).
Methods And Results:
Platelet-derived microparticles were obtained through centrifugation at various speeds, and their concentration was quantified using the BCA assay. To determine the size and immunophenotypic characteristics of the PMPs, both the DLS technique and flow cytometry were employed. Cell proliferation was assessed using the MTT assay and hemocytometer, and cell cycle analysis was conducted through DNA content evaluation. Real-time PCR was utilized for gene expression analysis of Bax, Bcl-2, Cyclin D1, P53, and P21. Flow cytometry was employed to examine cell apoptosis. The findings revealed that platelet-derived microparticles have the ability to decrease proliferation of the K562 cell line, while not exerting an impact on apoptosis and cell cycle progression. Analysis through real-time PCR indicated an upregulation in the gene expression of P53, P21, and Bcl-2, accompanied by a downregulation in Bax and Cyclin D1.
Conclusion:
This investigation sheds light on the intricate relationship between chronic myeloid leukemia and its microenvironment, particularly the involvement of platelet-derived microparticles. The study underscores the potential of platelet-derived microparticles to influence cell behavior and gene expression, providing a deeper understanding of their role in CML and its therapeutic implications.
Insights
Platelet-derived microparticles reduce chronic myeloid leukemia cell proliferation and alter gene expression, impacting cancer pathology. These microparticles influence key genes like P53 and Bcl-2, offering insights into CML progression.
Area of Science:
- Oncology
- Cell Biology
- Hematology
Background:
- The tumor microenvironment significantly influences cancer progression.
- Platelet-derived microparticles (PMPs) are key mediators of intercellular communication in cancer.
- Understanding PMP roles in chronic myeloid leukemia (CML) is crucial.
Purpose of the Study:
- To investigate the impact of PMPs on K562 CML cell proliferation, apoptosis, and cell cycle.
- To analyze the effect of PMPs on the expression of genes P53, P21, Cyclin D1, Bax, and Bcl-2.
Main Methods:
- PMPs isolated via centrifugation; concentration determined by BCA assay.
- PMP characterization using DLS and flow cytometry.
- Cell proliferation (MTT, hemocytometer), cell cycle (DNA content), apoptosis (flow cytometry), and gene expression (real-time PCR) analyzed.
Main Results:
- PMPs decreased K562 cell proliferation but did not affect apoptosis or cell cycle.
- Gene expression analysis revealed PMP-induced upregulation of P53, P21, and Bcl-2.
- Downregulation of Bax and Cyclin D1 gene expression was observed.
Conclusions:
- PMPs modulate K562 cell behavior and gene expression, highlighting their role in CML.
- Findings deepen the understanding of PMP involvement in CML pathogenesis.
- PMPs may represent a therapeutic target for chronic myeloid leukemia.
Related Concept Videos
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
01:15Differentiation of Common Myeloid Progenitor Cells